Contraception and Family Planning — MCQs

Contraception and Family Planning Indian Medical PG Practice Questions and MCQs

Question 421: All of the following conditions are contraindications for the use of a progestin-releasing intrauterine device, EXCEPT:

A. Carcinoma of the breast
B. Women with menorrhagia (Correct Answer)
C. Acute liver disease or tumor
D. Hypersensitivity to any component of this product

Explanation: **Explanation:** The **Progestin-releasing Intrauterine System (LNG-IUS)**, such as Mirena, is unique because it is both a contraceptive and a therapeutic device. **Why "Women with menorrhagia" is the correct answer:** Menorrhagia (heavy menstrual bleeding) is not a contraindication; rather, it is a **primary clinical indication** for the use of LNG-IUS. The local release of levonorgestrel causes profound endometrial atrophy, which reduces menstrual blood loss by approximately 90-97%. It is often considered the first-line medical management for Idiopathic Menorrhagia and heavy bleeding associated with adenomyosis or small fibroids. **Analysis of Contraindications (Incorrect Options):** * **Carcinoma of the Breast (Option A):** Progestin-only contraceptives are contraindicated (WHO Medical Eligibility Criteria Category 4) in women with current breast cancer because these tumors are often hormone-sensitive, and exogenous progestins may stimulate tumor growth. * **Acute Liver Disease or Tumor (Option C):** Steroid hormones are metabolized in the liver. Acute viral hepatitis, decompensated cirrhosis, and hepatocellular adenomas or carcinomas are contraindications for hormonal IUDs. * **Hypersensitivity (Option D):** Any known allergy to the components of the device (levonorgestrel or the silicone/polyethylene frame) is a standard absolute contraindication. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Primarily works by thickening cervical mucus and causing endometrial atrophy (prevents implantation). It is *not* primarily anovulatory. * **Non-contraceptive benefits:** Used in Endometrial Hyperplasia (without atypia), Adenomyosis, and as the progestogen component of Hormone Replacement Therapy (HRT). * **Common Side Effect:** Intermittent spotting or irregular bleeding is common in the first 3–6 months of use. * **Pearl:** Unlike the Copper-T, which can *increase* menstrual flow, the LNG-IUS is the gold standard for *reducing* it.

Question 422: Which contraceptive method offers protection against Pelvic Inflammatory Disease (PID) and Sexually Transmitted Diseases (STDs)?

A. Condoms (Correct Answer)
B. Copper-T (CuT)
C. Mala D (Oral Contraceptive Pill)
D. All of the above

Explanation: **Explanation:** The correct answer is **Condoms (Option A)**. Condoms act as a **mechanical barrier** that prevents the direct contact of genital mucosa and the exchange of infected bodily fluids (semen, vaginal secretions) during intercourse. By blocking the entry of pathogens like *Neisseria gonorrhoeae* and *Chlamydia trachomatis* into the upper genital tract, they significantly reduce the risk of both Sexually Transmitted Diseases (STDs) and subsequent Pelvic Inflammatory Disease (PID). **Why other options are incorrect:** * **Copper-T (CuT):** As an Intrauterine Device (IUD), it provides no protection against STDs. In fact, if inserted in a patient with an existing cervical infection, it may facilitate the ascent of bacteria into the uterus, potentially increasing the risk of PID in the first 20 days post-insertion. * **Mala D (OCPs):** While OCPs offer some protection against PID by thickening the cervical mucus (making it harder for bacteria to ascend), they provide **no protection** against STDs. In some cases, they may even increase the risk of certain infections (like *Chlamydia*) due to increased cervical ectopy. **High-Yield NEET-PG Pearls:** * **Dual Protection:** This refers to the simultaneous use of a condom (for STD/HIV prevention) and another highly effective contraceptive (like OCPs or IUDs) for pregnancy prevention. * **PID Protection:** While condoms are the primary method, OCPs are known to reduce the risk of **symptomatic** PID by approximately 50%. * **IUD & PID:** The risk of PID with an IUD is primarily related to the **insertion process** and pre-existing infections, not the device itself over the long term.

Question 423: The Standard Days Method (SDM) advises on avoiding unprotected sexual intercourse during which period of the menstrual cycle?

A. Day 3 to 13
B. Day 8 to 28
C. Day 8 to 21 (Correct Answer)
D. Day 3 to 19

Explanation: **Explanation:** The **Standard Days Method (SDM)** is a fertility awareness-based method of contraception designed for women with regular menstrual cycles lasting between **26 and 32 days**. It identifies a fixed "fertile window" during which unprotected intercourse should be avoided to prevent pregnancy. **1. Why Day 8 to 21 is Correct:** The SDM identifies **Days 8 through 21** of the menstrual cycle as the fertile period. This 14-day window accounts for: * The variation in the timing of ovulation (typically occurring 14 days before the next menses). * The lifespan of the sperm in the female reproductive tract (up to 5 days). * The lifespan of the ovum (approximately 24 hours). By avoiding unprotected sex during this interval, the probability of pregnancy is less than 5% with perfect use. **2. Analysis of Incorrect Options:** * **Option A (3–13) & D (3–19):** These ranges start too early. While menstruation occurs early in the cycle, the risk of conception is low before Day 8 in a standard cycle. * **Option B (8–28):** This range is unnecessarily long. While it covers the fertile window, it restricts intercourse during the "safe period" of the luteal phase (post-ovulation), making the method impractical. **3. Clinical Pearls for NEET-PG:** * **Cycle Requirement:** SDM is *only* effective for women whose cycles are consistently between 26 and 32 days. If a woman has more than one cycle outside this range in a year, she should switch methods. * **CycleBeads:** A visual aid (a string of color-coded beads) is often used to help users track their cycle. * **Pearl Index:** With typical use, the failure rate is approximately **12%**; with perfect use, it is **~5%**. * **Contraindication:** It is not suitable for women with irregular cycles, recent menarche, or those in the perimenopausal period.

Question 424: All except one is recommended for use in emergency contraception?

A. Combined oral contraceptives
B. Progestin only regimens
C. Selective oestrogen receptor modulators (Correct Answer)
D. Antiprogestins

Explanation: **Explanation:** Emergency contraception (EC) is intended to prevent pregnancy after unprotected intercourse or contraceptive failure. The correct answer is **Selective Estrogen Receptor Modulators (SERMs)**, as they are not used for emergency contraception; rather, they are primarily used in the treatment of breast cancer (Tamoxifen) or infertility (Clomiphene). **Why the other options are used:** * **Combined Oral Contraceptives (Option A):** Known as the **Yuzpe Regimen**, this involves two doses of ethinyl estradiol (100 mcg) and levonorgestrel (0.5 mg) taken 12 hours apart. It is less commonly used now due to high rates of nausea and vomiting. * **Progestin-only Regimens (Option B):** The **Levonorgestrel (LNG) 1.5 mg** single dose (or two 0.75 mg doses) is the most widely used hormonal EC. It works primarily by delaying ovulation. * **Antiprogestins (Option D):** **Ulipristal acetate (30 mg)** is a selective progesterone receptor modulator (SPRM) and is currently considered the most effective hormonal EC, effective up to 120 hours (5 days) after intercourse. **Mifepristone** (low dose) is also an effective antiprogestin used for EC. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** The **Copper-T 380A IUD** is the most effective method of emergency contraception (failure rate <0.1%) and can be inserted up to 5 days after intercourse. * **Time Window:** Hormonal methods are most effective within 72 hours, though Ulipristal is effective up to 120 hours. * **Mechanism:** EC prevents or delays ovulation; it is **not** an abortifacient and will not disrupt an established pregnancy. * **Drug of Choice:** Levonorgestrel is the DOC for lactating mothers and is available over-the-counter.

Question 425: Fimbriectomy is performed in which of the following procedures?

A. Pomeroy
B. Uchida
C. Kröner (Correct Answer)
D. Parkland

Explanation: **Explanation:** The correct answer is **Kröner’s technique**. This procedure involves a **fimbriectomy**, where the distal end of the fallopian tube (the fimbria) is ligated and excised. By removing the fimbriated end, the mechanism for ovum pickup is destroyed, providing a permanent method of sterilization. **Analysis of Options:** * **Kröner (Option C):** Specifically involves the resection of the fimbriated end of the tube. While effective, it is rarely performed today because it is irreversible and makes future tubal re-anastomosis (reversal) impossible. * **Pomeroy (Option A):** The most common method. It involves lifting a loop of the mid-segment of the tube, ligating the base with absorbable catgut, and excising the loop. * **Uchida (Option B):** A complex technique involving sub-serosal injection of saline/epinephrine, stripping the serosa, and burying the proximal stump into the broad ligament. It has the lowest failure rate. * **Parkland (Option D):** A mid-segment resection where the tube is ligated at two points and the intervening segment is excised, ensuring the ends are physically separated. **High-Yield NEET-PG Pearls:** * **Most common method:** Pomeroy’s technique (due to simplicity and safety). * **Lowest failure rate:** Uchida technique. * **Highest failure rate:** Madlener’s technique (crushing and ligating without excision). * **Ideal time for Postpartum Sterilization:** 24–48 hours after delivery. * **Failure Rate (Pearl Index):** For tubal ligation, it is approximately 0.5 per 100 woman-years.

Question 426: What is the Billing method?

A. A maneuver for the delivery of the head of the fetus
B. A method of contraception (Correct Answer)
C. Ethical guidelines for a better doctor-patient relationship
D. Assessing knowledge, attitude, and practice in society

Explanation: The **Billings Ovulation Method** is a natural family planning technique (fertility awareness-based method) used for contraception. It relies on the observation of changes in **cervical mucus** patterns throughout the menstrual cycle to identify the fertile window. ### Why the Correct Answer is Right: Under the influence of rising estrogen levels before ovulation, cervical mucus becomes thin, watery, clear, and stretchy (resembling raw egg white). This is known as **Spinnbarkeit**. After ovulation, progesterone makes the mucus thick, opaque, and tacky. By tracking these changes daily, a woman can identify "dry days" (infertile) and "wet days" (fertile) to avoid unprotected intercourse during the latter. ### Why Other Options are Wrong: * **Option A:** Maneuvers for the delivery of the fetal head include the **Ritgen maneuver** or the **Mauriceau-Smellie-Veit maneuver** (for breech). There is no "Billing maneuver" in obstetrics. * **Option C:** Ethical guidelines are governed by the **NMC (National Medical Commission)** and principles like autonomy, beneficence, and non-maleficence. * **Option D:** Assessing knowledge, attitude, and practice refers to a **KAP Study**, a common tool in Community Medicine/PSM. ### High-Yield Clinical Pearls for NEET-PG: * **Pearl Index:** The failure rate of the Billings method is approximately 3% with perfect use but significantly higher (up to 25%) with typical use. * **Spinnbarkeit Effect:** Refers to the elasticity of cervical mucus; it is maximum just before ovulation. * **Fern Test:** Estrogen causes the cervical mucus to form a palm-leaf/fern pattern on a slide, indicating the pre-ovulatory phase. * **Other Natural Methods:** Include the **Standard Days Method** (CycleBeads), **Symptothermal Method** (mucus + basal body temperature), and **Lactational Amenorrhea Method (LAM)**.

Question 427: Contraceptive vaginal foam tablets contain:

A. Nonoxynol 9 (Correct Answer)
B. Octoxynol 9
C. Menfegol
D. None of the above

Explanation: **Explanation:** **Nonoxynol-9 (N-9)** is the most widely used spermicide globally and is the primary active ingredient in contraceptive vaginal foam tablets, gels, and creams. It is a non-ionic surfactant that acts by disrupting the cell membrane (lipids) of the spermatozoa, leading to loss of motility and eventual cell death. **Analysis of Options:** * **A. Nonoxynol-9 (Correct):** It is the standard spermicide used in most over-the-counter vaginal contraceptives. It is effective against sperm but does not protect against STIs; in fact, frequent use can cause vaginal irritation, potentially increasing the risk of HIV transmission. * **B. Octoxynol-9:** While also a surfactant spermicide, it is less commonly used today than Nonoxynol-9 and is rarely the primary component in modern foam tablets. * **C. Menfegol:** This is a foaming agent and spermicide used primarily in certain regions (like Japan or parts of Europe) in the form of foaming tablets, but Nonoxynol-9 remains the "classic" answer for standardized exams regarding general foam tablet composition. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** Spermicides are "surface-active agents" that destroy the sperm cell membrane. 2. **Failure Rate:** When used alone, spermicides have a high typical-use failure rate (approx. 28%). They are best used in combination with barrier methods (e.g., diaphragms). 3. **Application:** Foam tablets must be inserted high into the vagina **10–15 minutes before** intercourse to allow for adequate dispersion. 4. **Vaginal pH:** Spermicides work best in an acidic environment; douching should be avoided for at least 6 hours after intercourse.

Question 428: Ulipristal acetate is used for which of the following conditions?

A. Endometriosis
B. Breast cancer
C. Emergency contraception (Correct Answer)
D. Abnormal uterine bleeding (AUB)

Explanation: **Explanation:** **Ulipristal acetate (UPA)** is a selective progesterone receptor modulator (SPRM). Its primary clinical application, and the correct answer here, is **Emergency Contraception (Option C)**. **Why Option C is correct:** Ulipristal acts by binding to progesterone receptors with high affinity, exerting an antagonistic effect. Its main mechanism is the **inhibition or delay of ovulation**. Unlike the levonorgestrel (LNG) pill, which must be taken within 72 hours and is ineffective once the LH surge has started, Ulipristal is effective for up to **120 hours (5 days)** after unprotected intercourse and can delay ovulation even after the LH surge has begun (but before it peaks). **Why other options are incorrect:** * **Option A (Endometriosis):** While some SPRMs are researched for endometriosis, Ulipristal is not the standard of care. GnRH analogues or progestins are preferred. * **Option B (Breast Cancer):** Antiestrogens (Tamoxifen) or Aromatase inhibitors are used here. Ulipristal is not indicated for breast malignancy. * **Option D (AUB):** While Ulipristal was previously used to treat **Uterine Fibroids** (to reduce volume and bleeding), its use for AUB/Fibroids has been severely restricted or suspended in many regions due to risks of **drug-induced liver injury**. **High-Yield Clinical Pearls for NEET-PG:** * **Dose:** 30 mg single dose for emergency contraception. * **Window:** Effective up to 120 hours (The "5-day pill"). * **Efficacy:** It is more effective than Levonorgestrel, especially in women with a higher BMI. * **Contraindication:** Severe asthma (due to its anti-glucocorticoid effect at high doses) and active liver disease. * **Note:** If a patient resumes regular hormonal contraception after taking UPA, they must use a barrier method for 14 days because UPA and progestins can interfere with each other.

Question 429: Which of the following is NOT a side effect of progesterone-only pills?

A. Irregular bleeding
B. Amenorrhea
C. Decreased lactation (Correct Answer)
D. Weight gain

Explanation: **Explanation:** The correct answer is **C. Decreased lactation**. Progesterone-only pills (POPs), often called the "minipill," are the hormonal contraceptive of choice for breastfeeding mothers. Unlike combined oral contraceptive pills (COCs), which contain estrogen that suppresses prolactin and significantly reduces the quantity and quality of breast milk, **progesterone does not inhibit lactation**. In fact, some studies suggest POPs may slightly increase milk volume or have a neutral effect, making them safe to initiate in the immediate postpartum period. **Analysis of Incorrect Options:** * **A. Irregular bleeding:** This is the most common side effect of POPs. Because they do not contain estrogen to stabilize the endometrium, users often experience breakthrough bleeding or spotting. * **B. Amenorrhea:** Over time, the progestogen causes endometrial atrophy, leading to a cessation of menses in a significant percentage of users. * **C. Weight gain:** While less pronounced than with injectable contraceptives (like DMPA), mild weight gain is a documented side effect of progestogens due to their anabolic effects and potential for increased appetite. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** POPs primarily work by thickening cervical mucus (preventing sperm penetration) and causing endometrial atrophy. They do not consistently suppress ovulation (only in ~50% of cycles). * **The "3-Hour Rule":** Traditional POPs must be taken at the same time every day. A delay of more than 3 hours is considered a "missed pill," requiring backup contraception for 48 hours. * **Ideal Candidate:** Lactating women, women over 35 who smoke, and those with contraindications to estrogen (e.g., history of VTE, migraine with aura, or uncontrolled hypertension).

Question 430: Which of the following is NOT a contraindication or consideration for contraception methods in patients with liver disease?

A. Combined oral contraceptive pills (OCPs) should not be initiated in women with active hepatitis.
B. Combined OCPs can be continued in women experiencing an acute flare-up of liver disease while already taking them.
C. Progestin-only contraception is the preferred method for patients with liver disease. (Correct Answer)
D. Discontinuing OCPs can resolve symptoms of cholestasis.

Explanation: ### Explanation This question tests the understanding of the **Medical Eligibility Criteria (MEC)** for contraceptive use in patients with liver disease. **1. Why Option C is the Correct Answer (The "NOT" Statement):** While progestin-only methods (like POPs or the Levonorgestrel-IUD) are generally safer than combined pills in liver disease, they are **not** universally the "preferred" method. According to WHO MEC guidelines, most hormonal contraceptives (including progestins) are contraindicated (MEC 3 or 4) in cases of **acute viral hepatitis, decompensated cirrhosis, and hepatocellular carcinoma** because the liver is the primary site for steroid metabolism. In many liver conditions, non-hormonal methods like the **Copper T (Cu-IUD)** are the actual "preferred" or safest choice. **2. Analysis of Incorrect Options:** * **Option A:** Correct clinical practice. COCPs are contraindicated (MEC 4) in **active hepatitis** because estrogens can worsen hepatic inflammation and interfere with bilirubin excretion. * **Option B:** Correct clinical practice. If a woman develops an acute flare-up of liver disease while already on COCPs, the medication should be **discontinued immediately** to prevent further hepatic stress. * **Option D:** Correct clinical practice. Estrogen is cholestatic. In conditions like **Cholestasis of Pregnancy** or pill-induced cholestasis, stopping the OCP leads to the resolution of pruritus and normalization of liver enzymes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Copper IUD:** The safest contraceptive (MEC 1) for almost all liver diseases, including cirrhosis and hepatoma. * **Rifampicin Interaction:** Patients being treated for TB (common in India) have induced liver enzymes, which reduces the efficacy of OCPs. * **Benign Liver Tumors:** COCPs are strictly contraindicated (MEC 4) in **Hepatic Adenoma** as they can cause tumor growth and rupture. * **MEC 4 for COCPs:** Active hepatitis, Decompensated cirrhosis, Hepatocellular carcinoma, and Gallbladder disease.

Practice by Chapter

Natural Family Planning Methods

Practice Questions

Barrier Methods

Practice Questions

Hormonal Contraceptives

Practice Questions

Intrauterine Devices

Practice Questions

Emergency Contraception

Practice Questions

Permanent Contraception Methods

Practice Questions

Contraception in Special Populations

Practice Questions

Contraceptive Counseling

Practice Questions

Side Effects and Complications of Contraceptives

Practice Questions

Future Contraceptive Technologies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free